Related Articles
A panel of markers for identification of malignant and non-malignant cells in culture from effusions
Tissue inhibitor of metalloproteinase 2 (TIMP-2) expression in adenocarcinoma pleural effusions
P53-immunoreactive cells in benign and malignant effusions: diagnostic value using a panel of monoclonal antibodies and comparison with CEA-staining.
Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma
Minimal residual disease detection in breast cancer: Improved sensitivity using cytokeratin 19 and epidermal growth factor receptor RT-PCR